
|Videos|November 22, 2017
Dr. Kumar Discusses Genetic Abnormalities in Myeloma
Author(s)Shaji K. Kumar, MD
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.
Advertisement
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.
There has been significant progress toward understanding genetic variations in patients with multiple myeloma.
Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5



































